Tissue-engineered tubular grafts
Tissue-engineered tubular grafts has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jun 23, 2026: “A novel tubular construct using silk fibroin-chitosan scaffold seeded with bone marrow mesenchymal stem cells for urinary diversion in a preclinical rabbit model”.
1 paper studies it2 findingsUpdated
See all 1 papers on tissue-engineered tubular grafts
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Animals1
What did studies of tissue-engineered tubular grafts find?
2Studies of tissue-engineered tubular grafts measured 2 outcomes; the most studied are stenosis (1 study) and mortality (1).
Stenosis
downin O. cuniculus1
1 study
Stenosis
downin O. cuniculus1
Tissue-engineered tubular grafts prevent stenosis in O. cuniculus (urinary diversion).
“IVU confirmed patent outflow tracts without stenosis, urinary fistula, hydronephrosis, or ureteral dilation.”
Animalsurinary diversion10 weeksn = 24
Frontiers in surgery
Mortality
downin O. cuniculus1
1 study
Mortality
downin O. cuniculus1
Tissue-engineered tubular grafts decrease mortality in O. cuniculus (urinary diversion).
“All rabbits in the experimental group survived, showing luminal urothelial growth, with complete epithelialization achieved by week 8.”
Animalsurinary diversionsilk fibroin/chitosan seeded with BMSCs and SMCsn = 24
Frontiers in surgery